Is modafinil really that good?
Modafinil was dubbed the “world’s first safe smart drug” by researchers at Harvard and Oxford universities who suggested its effects were “low risk” when taken in the short term. But side effects can include insomnia, headaches and potentially dangerous skin rashes, and there is a lack of long-term data.
Can you still feel tired on modafinil?
Modafinil may cause some people to feel dizzy, drowsy, have trouble thinking or controlling movements, or trouble seeing clearly. Make sure you know how you react to this medicine before you drive, use machines, or do other jobs that require you to be alert, well-coordinated, or able to think or see well.
Is there a better drug than modafinil?
Armodafinil may have a longer half-life compared to modafinil (brand-name Provigil). In some cases, armodafinil may be considered a stronger drug with better wakefulness effects. While both drugs can have similar side effects, some side effects may be more common in one drug versus the other.
Does modafinil actually make you smarter?
Now, a new systematic review, published online in the peer-reviewed journal European Neuropsychopharmacology shows that modafinil does indeed confer significant cognitive benefits in this group, at least on a particular subset of tasks. …
Do you lose weight on modafinil?
Reinstitution of modafinil resulted in a 10-lb. weight loss over a 6-week period. Conclusions: Modafinil treatment resulted in a significant weight loss in this patient, possibly due to reducing clozapine-associated fatigue.
Can modafinil cause weight gain?
A 30-lb weight gain over a 6-month period occurred following discontinuation of modafinil. Reinstitution of modafinil resulted in a 10-lb. weight loss over a 6-week period. Conclusions: Modafinil treatment resulted in a significant weight loss in this patient, possibly due to reducing clozapine-associated fatigue.
Why is modafinil so expensive?
Their expensiveness is mainly due to the fact that the original drug maker performs costly research & development (R&D) activities. The company also spends much on marketing. So it raises the prices of Provigil & Nuvigil to cover the drug R&D costs. Both products are also available as generic meds.
Why isn’t modafinil used for ADHD?
This use is not approved by the FDA, but some research has shown improvement in ADHD symptoms when compared to a placebo. According to the FDA, modafinil is a federally controlled substance (C-IV) because it can be abused or lead to dependence. The safety and effectiveness for children has not been established.
Does modafinil make you lose weight?
Provigil can cause loss of appetite in some people who take it. Because of this side effect, some people misuse Provigil as a weight loss aid. Don’t take Provigil unless your doctor has prescribed it for you.
What are the reviews of modafinil on Drugs.com?
Modafinil has an average rating of 7.3 out of 10 from a total of 407 ratings on Drugs.com. 64% of users who reviewed this medication reported a positive effect, while 18% reported a negative effect. Reviews may be moderated to correct grammar/spelling or remove inappropriate language.
What are the ratings for modafinil for narcolepsy?
Modafinil has an average rating of 6.6 out of 10 from a total of 135 ratings for the treatment of Narcolepsy. 55% of reviewers reported a positive effect, while 25% reported a negative effect. Provigil (modafinil): “Provigil has changed my life!
How is modafinil used in the treatment of EDS?
Thus, modafinil is effective in the treatment of EDS in patients with narcolepsy, although it is not effective against cataplexy. Preliminary findings indicate that, unlike other psychostimulants, the drug is unlikely to be abused and is not associated with withdrawal phenomena.
How is modafinil used to treat sleep deprivation?
Modafinil reduced the impairment of cognitive performance induced by sleep deprivation in volunteers, suppressed microsleeps and reduced the length of recovery sleep required. However, volunteers treated with modafinil reported recovery sleep patterns which were similar to those of placebo recipients.